Stocks and Investing Stocks and Investing
Fri, August 11, 2023

David Nierengarten Maintained (VOR) at Buy with Decreased Target to $11 on, Aug 11th, 2023


Published on 2024-10-28 05:49:41 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $18 to $11 on, Aug 11th, 2023.

David has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Justin Walsh of "JonesTrading" Initiated at Strong Buy and Held Target at $18 on, Tuesday, May 16th, 2023
  • Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $18 on, Monday, May 15th, 2023

Contributing Sources